Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Bearish
2
Neutral
7
Bullish
5
Bearish
19
Neutral
7
Bullish
20
Bearish
17
Neutral
0
Bullish
15
Discovery themes featuring this stock
Narayana Hrudayalaya Limited is a multi‑speciality and super‑speciality healthcare operator founded by Dr. Devi Prasad Shetty, running a network of hospitals, clinics and management‑run facilities across India and international markets including Cayman Islands and the UK, offering tertiary care, robotic procedures, oncology and cardiac services alongside integrated care and an insurance business.
Recent quarters show meaningful margin expansion in the India portfolio driven by a multi‑year transformation: payor‑mix optimisation, higher‑realisation cases including robotic cardiac and bone marrow transplants, and technology infusion have driven 150–200 bps YoY margin improvement in the India business with management intent to sustain these gains where possible.
The Group has accelerated international footprint via a material UK acquisition (Practice Plus) and continued Cayman investment; the UK deal was funded with substantial debt (GBP 150m) and equity (GBP 45m) and is expected to be EBITDA neutral to mildly accretive over time after integration and operational efficiencies, while creating short‑term ROCE normalization.
Narayana is investing in an integrated care stack — clinics, pharmacies, and insurance (NHIC) — accepting near‑term losses to build distribution and cross‑sell; management is deliberately merging clinic operations into NHL and reporting insurance separately, with losses narrowing but breakeven timelines still uncertain as investments continue.
Healthcare Services
Hospital
36,172 Cr
Low Risk
46.0
56.0
1.3
8.9
2,371.60
1,564.25
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
658.90 | 36,548 Cr | 103.87 | 8.73 | 0.68 | 8.18 | 10.11 | 4.60 | ||
1765.00 | 36,172 Cr | 46.02 | 8.91 | 0.25 | 20.82 | 17.75 | 10.07 | ||
1001.30 | 29,724 Cr | 52.41 | 8.02 | 0.00 | 15.15 | 16.83 | 9.50 | ||
680.00 | 26,093 Cr | 90.67 | 11.49 | 0.00 | 14.80 | 10.88 | 4.75 | ||
441.30 | 13,881 Cr | 111.38 | 7.19 | 0.00 | 5.94 | 9.26 | 4.25 | ||
1254.90 | 12,568 Cr | 49.47 | 8.28 | 0.24 | 16.72 | 17.60 | 10.05 | ||
195.70 | 10,025 Cr | 35.26 | 5.12 | 0.00 | 20.61 | 19.00 | 0.00 | ||
| Median: 7 Co. | — | 680.00 | 26,093 Cr | 52.41 | 8.28 | 0.00 | 15.15 | 16.83 | 4.75 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Narayana Hrudayalaya Ltd (NH) is currently trading at 1,777.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Narayana Hrudayalaya Limited is a multi‑speciality and super‑speciality healthcare operator founded by Dr. Devi Prasad Shetty, running a network of hospitals, clinics and management‑run facilities across India and international markets including Cayman Islands and the UK, offering tertiary care, robotic procedures, oncology and cardiac services alongside integrated care and an insurance business. Recent quarters show meaningful margin expansion in the India portfolio driven by a multi‑year transformation: payor‑mix optimisation, higher‑realisation cases including robotic cardiac and bone marrow transplants, and technology infusion have driven 150–200 bps YoY margin improvement in the India business with management intent to sustain these gains where possible. The Group has accelerated international footprint via a material UK acquisition (Practice Plus) and continued Cayman investment; the UK deal was funded with substantial debt (GBP 150m) and equity (GBP 45m) and is expected to be EBITDA neutral to mildly accretive over time after integration and operational efficiencies, while creating short‑term ROCE normalization. Narayana is investing in an integrated care stack — clinics, pharmacies, and insurance (NHIC) — accepting near‑term losses to build distribution and cross‑sell; management is deliberately merging clinic operations into NHL and reporting insurance separately, with losses narrowing but breakeven timelines still uncertain as investments continue.
Over the past 52 weeks, Narayana Hrudayalaya Ltd has traded between a low of ₹1,564.25 and a high of ₹2,371.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Narayana Hrudayalaya Ltd has a market capitalization of approximately 36,171.86. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Narayana Hrudayalaya Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 46.02 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 36,171.86 Cr, Narayana Hrudayalaya Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Narayana Hrudayalaya Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Narayana Hrudayalaya Ltd is 46.02. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The stock price increased by 3% after the company announced the purchase of a 3.3-acre property in Bengaluru's Electronic City for business expansion, including setting up a Global Capability Center.
The meetings were held to seek approval from equity shareholders, secured creditors, and unsecured creditors for the proposed scheme of arrangement involving the demerger of NH Integrated Care Private Limited into Narayana Hrudayalaya Limited.
The main outcome was the overwhelming approval from shareholders and creditors for the scheme of arrangement involving the demerger with NH Integrated Care Private Limited.
The most significant positive is the proposed scheme to develop five regional medical hubs in partnership with the private sector, which will provide a major boost to the medical tourism segment, a key strength for Narayana Hrudayalaya.
